July 14, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will review on July 27 whether to recommend approval for a batch of drugs including Pfizer’s breast cancer drug palbociclib, known as Ibrance overseas. According to Pfizer,...read more